TG Therapeutics | Kontanter Og Tilsvarende



Cash And Equivalent Endring Dato
AbbVie USD 5.52B 1.73B 2024-12
Alaunos Therapeutics USD 1.68M 780K 2024-09
Amgen USD 11.97B 2.96B 2024-12
Ardelyx USD 48.65M 8.78M 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
Bayer EUR 6.19B 1.57B 2024-12
Biogen USD 2.38B 675.8M 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Dynavax Technologies USD 95.88M 23.45M 2024-12
Gilead Sciences USD 9.99B 4.95B 2024-12
J&J USD 6.12B 1.28B 2024-12
Novartis USD 8.87B 4.74B 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
TG Therapeutics USD 179.89M 15.93M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



TG Therapeutics Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.